| Front Range Hospice & Palliative Care 3770 Puritan Way Suite E, Frederick, CO, 80530 | |
| (303) 957-3101 |
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA.
Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.
A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.
EntreMed, Inc., a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study.
A major review by experts concludes that abortion does not raise the risk of a woman suffering mental health problems. Data from 44 studies showed women with an unwanted pregnancy have a higher incidence of mental health problems in general. This is not affected by whether or not they have an abortion or give birth.
› Verified 9 days ago
| Name | Front Range Hospice & Palliative Care |
|---|---|
| Location | 3770 Puritan Way Suite E, Frederick, Colorado |
| Hospice ID | 061561 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 610 |
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA.
Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.
A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.
EntreMed, Inc., a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study.
A major review by experts concludes that abortion does not raise the risk of a woman suffering mental health problems. Data from 44 studies showed women with an unwanted pregnancy have a higher incidence of mental health problems in general. This is not affected by whether or not they have an abortion or give birth.
› Verified 9 days ago
| NPI Number | 1629090725 |
| Organization Name | Wlh, Llc |
| Address | 3770 Puritan Way Unit E Frederick, Colorado, 80516 |
| Phone Number | (303)957-3101 |
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA.
Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.
A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.
EntreMed, Inc., a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study.
A major review by experts concludes that abortion does not raise the risk of a woman suffering mental health problems. Data from 44 studies showed women with an unwanted pregnancy have a higher incidence of mental health problems in general. This is not affected by whether or not they have an abortion or give birth.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 87.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 83.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 49.4 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 81.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.4 | 93.3 |
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA.
Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.
A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.
EntreMed, Inc., a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study.
A major review by experts concludes that abortion does not raise the risk of a woman suffering mental health problems. Data from 44 studies showed women with an unwanted pregnancy have a higher incidence of mental health problems in general. This is not affected by whether or not they have an abortion or give birth.
› Verified 9 days ago
| Home Health Aides | 3 |
| Counselors | 2 |
| Medical Social Workers | 5 |
| Registered Nurses | 7 |
| Other Personnel | 6 |
| Total Employees | 23 |
|---|
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA.
Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.
A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.
EntreMed, Inc., a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study.
A major review by experts concludes that abortion does not raise the risk of a woman suffering mental health problems. Data from 44 studies showed women with an unwanted pregnancy have a higher incidence of mental health problems in general. This is not affected by whether or not they have an abortion or give birth.
› Verified 9 days ago
| Front Range Hospice & Palliative Care Location: 3770 Puritan Way Suite E, Frederick, Colorado, 80530 Phone: (303) 957-3101 |